Thomas J. Layden - Concepedia

Author

Thomas J. Layden

Also Known As

T J Layden, T LAYDEN, T Layden, T. J. Layden, T. LAYDEN, T. Layden, T.J. Layden, T. J. Layden, Thomas J Layden, Thomas J. Layden

151

Publications

8.4K

Citations

H-Index

135

Concepts

All Affiliations

University of Illinois Chicago Los Alamos National Laboratory University of Chicago Bar-Ilan University University of Chicago Medical Center

About

Thomas J. Layden is an author at University of Illinois Chicago specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	51	3K
2	Health Sciences	7	7	408
3	Public Health	6	6	169
4	Allergy	1	1	13
5	Anesthesia	1	1	10

Thomas J. Layden

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy Avidan U. Neumann, Nancy P. Lam, Harel Dahari, Science	1998	2.1K
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection Narendra M. Dixit, Jennifer E. Layden‐Almer, Thomas J. Layden, Nature Viral PersistenceHepatologyViral HepatitisImmunologyAntiviral Therapy	2004	369
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life Jérémie Guedj, Harel Dahari, Libin Rong, Proceedings of the National Academy of Sciences Shorter EstimateViral PersistenceHepatitis CViral HepatitisMedicine	2013	335
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Natalie Lam, Avidan U. Neumann, David R. Gretch, Hepatology	1997	329
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C† Hongjin Huang, Mitchell L. Shiffman, Scott L. Friedman, Hepatology	2007	298
Differences in Viral Dynamics between Genotypes 1 and 2 of Hepatitis C Virus Avidan U. Neumann, Nancy P. Lam, Harel Dahari, The Journal of Infectious Diseases	2000	227
Viral Dynamics and Response Differences in Hcv–Infected African American and White Patients Treated With Ifn and Ribavirin Jennifer E. Layden‐Almer, Ruy M. Ribeiro, Thelma E. Wiley, Hepatology	2003	185
Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Grace Guzman, Elizabeth M. Brunt, Lydia M. Petrovic, PubMed	2008	185
Does Nonalcoholic Fatty Liver Disease Predispose Patients to Hepatocellular Carcinoma in the Absence of Cirrhosis? Grace Guzman, Elizabeth M. Brunt, Lydia M. Petrovic, Archives of Pathology & Laboratory Medicine	2008	178
Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1 Christos Hadjiagapiou, Larry Schmidt, Pradeep K. Dudeja, American Journal of Physiology-Gastrointestinal and Liver Physiology	2000	176

Page 1